The 30th Annual Meeting of the Japanese Society for Vaccinology/The 67th Annual Meeting of the Japanese Society of Clinical Virology

*Takayori Ono¹, Kiyoto Naito² (1. Japan Medical Office, Takeda Pharmaceutical Company Limited, 2. Global Evidence Generation, Takeda Pharmaceutical Company Limited)

*Manami Nakashita^1,2, Manami Negoro³, Kentaro Yamamoto³, Yumani Kuba², Yusuke Kobayashi², Rie Koshida⁴, Masami Kitaoka⁴, Nao Kobashi⁵, Hiroe Kodama⁵, Kiyosu Taniguchi^3,6, Shigeru Suga³, Motoi Suzuki², Tomimasa Sunagawa², Hajime Kamiya^6,2, Kanazawa-city mumps study group (1. Showa Pharmaceutical University, 2. National Institute of Infectious Diseases, Japan Institute for Health Security, 3. National Hospital Organization Mie National Hospital, 4. Health Center, Kanazawa City Health and Welfare Department, 5. Ishikawa Prefectural Institute of Public Health and Environmental Science, 6. Graduate School of Medicine, Mie University)

*Toshihiro Tanaka¹, Kazuya Nakamura², Haruna Ogishima², Ayuko Tsuji² (1. Department of Pediatrics, Shizuoka Kosei Hospital, JAPAN, 2. Department of Clinical Laboratory, Shizuoka Kosei Hospital, JAPAN)

*Etsuro Nanishi^2,1, Matthew Hwang², Ana Citlali Márquez^3,4, Walter Byrne², Maria-Rosa La Neve², Alice Litosh², Jasmik S Saini², Kimberly Thompson², Nicole Wisener², Makiko Nanishi², Julia EM Upton², Aaron Campigotto², Michelle Barton⁵, Agatha N. Jassem³, Upton D. Allen² (1. Fukuoka Children's Hospital, 2. The Hospital for Sick Children, University of Toronto, Canada, 3. British Columbia Centre for Disease Control, Canada, 4. University of British Columbia, Canada, 5. University of Western Ontario, Canada)

*Joonho Shin^1,2, Tatsuki Ikuse^1,2, Meiwa Shibata^1,2, Yuho Horikoshi^1,2 (1. Division of Infectious Diseases, Immunology Department of Pediatrics Tokyo Metropolitan Children’s Medical Center, 2. Center for Pediatric Infectious Diseases Tokyo Metropolitan Children’s Medical Center)